SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹13,752 Cr | ₹11,088 Cr | ₹9,408 Cr | ₹4,481 Cr | ₹2,799 Cr |
| Adjustment | ₹1,120 Cr | ₹1,554 Cr | ₹2,723 Cr | ₹1,975 Cr | ₹1,810 Cr |
| Changes In working Capital | ₹-324 Cr | ₹1,062 Cr | ₹-5,662 Cr | ₹1,559 Cr | ₹2,564 Cr |
| Cash Flow after changes in Working Capital | ₹14,549 Cr | ₹13,704 Cr | ₹6,469 Cr | ₹8,015 Cr | ₹7,173 Cr |
| Cash Flow from Operating Activities | ₹14,072 Cr | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr | ₹6,170 Cr |
| Cash Flow from Investing Activities | ₹-5,306 Cr | ₹-690 Cr | ₹-7,944 Cr | ₹-5,725 Cr | ₹536 Cr |
| Cash Flow from Financing Activities | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr | ₹-5,980 Cr |
| Net Cash Inflow / Outflow | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr | ₹726 Cr |
| Opening Cash & Cash Equivalents | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr | ₹6,273 Cr | ₹5,677 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹-0.03 Cr | ₹1.29 Cr | ₹567 Cr | ₹41 Cr | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹123 Cr | ₹-74 Cr | ₹157 Cr | ₹127 Cr | ₹-130 Cr |
| Closing Cash & Cash Equivalent | ₹10,269 Cr | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr | ₹6,273 Cr |
Compare Cashflow Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,552.8 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
| MANKIND PHARMA | ₹88,996.6 Cr | 2.6% | -2.1% | -16.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 7.1% |
-1.5% |
-6.2% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses